Page de couverture de JAMA Ophthalmology Author Interviews

JAMA Ophthalmology Author Interviews

JAMA Ophthalmology Author Interviews

Auteur(s): JAMA Network
Écouter gratuitement

À propos de cet audio

 Interviews with authors of articles from JAMA Ophthalmology. JAMA Ophthalmology, published continuously since 1869, is an international, peer-reviewed ophthalmology and visual science journal. Covering research, science, & clinical practice in ophthalmology and vision science.2024 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies. Hygiène et mode de vie sain Science Troubles et maladies
Épisodes
  • Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy

    Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy
    Aug 7 2025

    Interview with Ehsan Rahimy, MD, author of Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative Vitreoretinopathy. Hosted by Neil Bressler, MD.

    Related Content:

    • Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative Vitreoretinopathy
    Voir plus Voir moins
    18 min
  • Steroids and Cross-Linking for Ulcer Treatment

    Steroids and Cross-Linking for Ulcer Treatment
    Jul 24 2025

    Interview with Jennifer R. Rose-Nussbaumer, MD, author of Steroids and Cross-Linking for Ulcer Treatment: The SCUT II Randomized Clinical Trial. Hosted by Neil Bressler, MD.

    Related Content:

    • Steroids and Cross-Linking for Ulcer Treatment
    Voir plus Voir moins
    15 min
  • From the JAMA Network: GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension

    From the JAMA Network: GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension
    Jul 17 2025

    Interview with Dennis J. Rivet II, MD, author of GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension. Hosted by Cynthia E. Armand, MD.

    Related Content:

    • GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension
    Voir plus Voir moins
    22 min
Pas encore de commentaire